On July 22, 2026, Jubilant Ingrevia Limited announced its consolidated unaudited financial results for the quarter ended June 30, 2026, as per the exchange filings.
The company reported a notable increase in both total income and net profit compared to the previous year and the preceding quarter.
In the June 2026 quarter, Jubilant Ingrevia Limited's total income rose by 24.9% year-on-year (YoY) to ₹1,310.49 crore, compared to ₹1,049.17 crore in the same quarter of the previous year.
Sequentially, the total income increased by 10.3% from ₹1,187.96 crore in the March 2026 quarter.
Net profit for the June 2026 quarter saw a 40.9% YoY increase, reaching ₹105.82 crore, up from ₹75.10 crore a year ago.
On a quarter-on-quarter (QoQ) basis, net profit rose by 22.4% from ₹86.44 crore in the March 2026 quarter.
For the financial year 2026 (FY26), Jubilant Ingrevia Limited reported a total income of ₹4,428.60 crore. The net profit for the year stood at ₹277.91 crore, reflecting the company's overall financial performance for the fiscal year.
Read More: UltraTech Cement Share Price in Focus After Q1 FY27 Earnings Results: Total Income Up 15.5% YoY!
Jubilant Ingrevia Limited is a global life science and chemical solutions provider specializing in Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. Headquartered in Noida, India, it operates as part of the Jubilant Bhartia Group.
As of July 22, 2026, at 1:49 PM, Jubilant Ingrevia share price on NSE was trading at ₹736.70, down by 3.55% from the previous closing price.
Jubilant Ingrevia Limited's Q1 FY27 results show a 24.9% YoY increase in total income to ₹1,310.49 crore and a 40.9% YoY rise in net profit to ₹105.82 crore. The company's FY26 total income was ₹4,428.60 crore, with a net profit of ₹277.91 crore.
Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 22, 2026, 2:05 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
